Edenville Energy PLC Q&A with CEO Rufus Short: Partnership with Sinohydro Corporation 26 January 2017
Allergy Therapeutics plc Q&A with Zeus Capital’s Healthcare Research Director Dr Gary Waanders (LON:AGY) 24 January 2017
Firering Strategic Minerals set to receive $1m settlement following Ricca EGM approval 12 December 2025
Global Opportunities Trust reaffirms successful value and absolute-return strategy (LON: GOT) 12 December 2025
Prediction markets move into the mainstream as trading surges | Ruffer Investment Company 12 December 2025
Global Opportunities Trust Reaffirms Successful Value and Absolute-Return Strategy (LON: GOT) 11 December 2025
Dechra Pharmaceuticals deliver a resilient performance with group revenue growth of 5.5% 12 October 2023
XPS Pensions Group (XPS.L) Investor Outlook: Navigating a 32% Potential Upside Amid Robust Analyst Confidence 12 December 2025
Vesuvius PLC (VSVS.L) Stock Analysis: A 6.15% Dividend Yield Amidst Market Challenges 12 December 2025
ZIGUP PLC ORD 50P (ZIG.L): Exploring a 25.92% Potential Upside Amidst Solid Dividend Yields 12 December 2025
Wizz Air Holdings PLC (WIZZ.L) Stock Analysis: Navigating Market Turbulence with a Promising 18.48% Upside 12 December 2025
Edenville Energy PLC Q&A with CEO Rufus Short: Partnership with Sinohydro Corporation 26 January 2017
Allergy Therapeutics plc Q&A with Zeus Capital’s Healthcare Research Director Dr Gary Waanders (LON:AGY) 24 January 2017
Firering Strategic Minerals set to receive $1m settlement following Ricca EGM approval 12 December 2025
Global Opportunities Trust reaffirms successful value and absolute-return strategy (LON: GOT) 12 December 2025
Prediction markets move into the mainstream as trading surges | Ruffer Investment Company 12 December 2025
Global Opportunities Trust Reaffirms Successful Value and Absolute-Return Strategy (LON: GOT) 11 December 2025
Dechra Pharmaceuticals deliver a resilient performance with group revenue growth of 5.5% 12 October 2023
XPS Pensions Group (XPS.L) Investor Outlook: Navigating a 32% Potential Upside Amid Robust Analyst Confidence 12 December 2025
Vesuvius PLC (VSVS.L) Stock Analysis: A 6.15% Dividend Yield Amidst Market Challenges 12 December 2025
ZIGUP PLC ORD 50P (ZIG.L): Exploring a 25.92% Potential Upside Amidst Solid Dividend Yields 12 December 2025
Wizz Air Holdings PLC (WIZZ.L) Stock Analysis: Navigating Market Turbulence with a Promising 18.48% Upside 12 December 2025
Inspire Medical Systems, Inc. Share Price Target ‘$232.93’, now 29.3% Upside Potential 20 February 2025
UnitedHealth Group Incorporated Share Price Target ‘$637.24’, now 27.3% Upside Potential 20 February 2025
Webster Financial Corporation Share Price Target ‘$70.71’, now 19.7% Upside Potential 20 February 2025
Sensata Technologies Holding plc Share Price Target ‘$36.72’, now 23.8% Upside Potential 20 February 2025
Edenville Energy PLC Q&A with CEO Rufus Short: Partnership with Sinohydro Corporation 26 January 2017
Allergy Therapeutics plc Q&A with Zeus Capital’s Healthcare Research Director Dr Gary Waanders (LON:AGY) 24 January 2017
Global Opportunities Trust reaffirms successful value and absolute-return strategy (LON: GOT) 12 December 2025
Prediction markets move into the mainstream as trading surges | Ruffer Investment Company 12 December 2025
Global Opportunities Trust Reaffirms Successful Value and Absolute-Return Strategy (LON: GOT) 11 December 2025
Firering Strategic Minerals set to receive $1m settlement following Ricca EGM approval 12 December 2025
XPS Pensions Group (XPS.L) Investor Outlook: Navigating a 32% Potential Upside Amid Robust Analyst Confidence 12 December 2025
Vesuvius PLC (VSVS.L) Stock Analysis: A 6.15% Dividend Yield Amidst Market Challenges 12 December 2025
ZIGUP PLC ORD 50P (ZIG.L): Exploring a 25.92% Potential Upside Amidst Solid Dividend Yields 12 December 2025
Wizz Air Holdings PLC (WIZZ.L) Stock Analysis: Navigating Market Turbulence with a Promising 18.48% Upside 12 December 2025
